Publicaciones en colaboración con investigadores/as de Harvard Medical School (2)

2017

  1. Comparison of fatal or irreversible events with extended-duration betrixaban versus standard dose enoxaparin in acutely Ill medical patients: An APEX trial substudy

    Journal of the American Heart Association, Vol. 6, Núm. 7

2016

  1. Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry

    Journal of the American Heart Association, Vol. 5, Núm. 10